Abstract
The feasibility of in vitro mature mouse hepatocyte labeling with a novel iron oxide particle was assessed and the ability of 1.5-T magnetic resonance imaging (MRI) to track labeled mouse hepatocytes in syngenic recipient livers following intraportal cell transplantation was tested. Mouse hepatocytes were incubated with anionic iron oxide nanoparticles at various iron concentrations. Cell viability was assessed and iron oxide particle uptake quantified. Labeled hepatocytes were intraportally injected into 20 mice, while unlabeled hepatocytes were injected into two mice. Liver T2 values, spleen-to-muscle relative signal intensity (RI spleen/muscle ), and liver-to-muscle relative signal intensity (RI liver/muscle ) on gradient-echo T2-weighted imaging after injection of either labeled or unlabeled hepatocytes were compared with an ANOVA test followed by Fisher’s a posteriori PLSD test. Livers, spleens and lungs were collected for histological analysis. Iron oxide particle uptake was saturable with a maximum iron content of 20 pg per cell and without viability alteration after 3 days of culture. Following labeled-cell transplantation, recipient livers showed well-defined nodular foci of low signal intensity on MRI—consistent with clusters of labeled hepatocytes on pathological analysis—combined with a significant decrease in both liver T2 values and liver-to-muscle RI liver/muscle (P = 0.01) with minimal T2 values demonstrated 8 days after transplantation. Conventional MRI can demonstrate the presence of transplanted iron-labeled mature hepatocytes in mouse liver.
Similar content being viewed by others
References
Horslen SP, Fox IJ (2004) Hepatocyte transplantation. Transplantation 77:1481–1486
Fox IJ, Roy-Chowdhury J (2004) Hepatocyte transplantation. J Hepatol 40:878–886
Fox IJ, Chowdhury JR (2004) Hepatocyte transplantation. Am J Transplant 4(Suppl 6):7–13
Lee SW, Wang X, Chowdhury NR, Roy-Chowdhury J (2004) Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles. Ann Hepatol 3:48–53
Grossman M, Raper SE, Wilson JM (1992) Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity. Hum Gene Ther 3:501–510
Holzman MD, Rozga J, Neuzil DF, Griffin D, Moscioni AD, Demetriou AA (1993) Selective intraportal hepatocyte transplantation in analbuminemic and Gunn rats. Transplantation 55:1213–1219
Rozga J, Holzman M, Moscioni AD, Fujioka H, Morsiani E, Demetriou AA (1995) Repeated intraportal hepatocyte transplantation in analbuminemic rats. Cell Transplant 4:237–243
Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P, Meroni M, Giron G, Burlina AB (2002) Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359:317–318
Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R, Bernard Otte J, Evrard V, Latinne D, Vincent MF, Moser A, Soriano HE (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76:735–738
Horslen SP, McCowan TC, Goertzen TC, Warkentin PI, Cai HB, Strom SC, Fox IJ (2003) Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262–1267
Wilson JM, Grossman M, Wu CH, Chowdhury NR, Wu GY, Chowdhury JR (1992) Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J Biol Chem 267:963–967
Chowdhury JR, Grossman M, Gupta S, Chowdhury NR, Baker JR Jr, Wilson JM (1991) Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 254:1802–1805
Wang J, Li W, Min J, Ou Q, Chen J, Song E (2004) Intrasplenic transplantation of allogeneic hepatocytes modified by BCL-2 gene protects rats from acute liver failure. Transplant Proc 36:2924–2926
Sigot V, Mediavilla MG, Furno G, Rodriguez JV, Guibert EE (2004) A simple and effective method to improve intrasplenic rat hepatocyte transplantation. Cell Transplant 13:775–781
Ponder KP, Gupta S, Leland F, Darlington G, Finegold M, DeMayo J, Ledley FD, Chowdhury JR, Woo SL (1991) Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci USA 88:1217–1221
Allen KJ, Soriano HE (2001) Liver cell transplantation: the road to clinical application. J Lab Clin Med 138:298–312
Grompe M (2006) Principles of therapeutic liver repopulation. J Inherit Metab Dis 29:421–425
Andreoletti M, Loux N, Vons C, Nguyen TH, Lorand I, Mahieu D, Simon L, Di Rico V, Vingert B, Chapman J, Briand P, Schwall R, Hamza J, Capron F, Bargy F, Franco D, Weber A (2001) Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates: implication for ex vivo gene therapy. Hum Gene Ther 12:169–179
Vons C, Loux N, Simon L, Mahieu-Caputo D, Dagher I, Andreoletti M, Borgnon J, Di Rico V, Bargy F, Capron F, Weber A, Franco D (2001) Transplantation of hepatocytes in nonhuman primates: a preclinical model for the treatment of hepatic metabolic diseases. Transplantation 72:811–818
Ferry N, Duplessis O, Houssin D, Danos O, Heard JM (1991) Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci USA 88:8377–8381
Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr (1997) Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 7:258–263
Moore A, Marecos E, Bogdanov A Jr, Weissleder R (2000) Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568–574
Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18:410–414
Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19:1141–1147
Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA (2003) Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 76:1123–1130
Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, Poremba C, Ebert W, Heindel W, Bremer C (2005) Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 235:155–161
Smirnov P, Lavergne E, Gazeau F, Lewin M, Boissonnas A, Doan BT, Gillet B, Combadiere C, Combadiere B, Clement O (2006) In vivo cellular imaging of lymphocyte trafficking by MRI: A tumor model approach to cell-based anticancer therapy. Magn Reson Med 56:498–508
Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F (2003) Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24:1001–1011
Seglen PO (1976) Preparation of isolated rat liver cells. Methods Cell Biol 13:29–83
Billotey C, Wilhelm C, Devaud M, Bacri JC, Bittoun J, Gazeau F (2003) Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn Reson Med 49:646–654
Wilhelm C, Gazeau F, Bacri JC (2002) Magnetophoresis and ferromagnetic resonance of magnetically labeled cells. Eur Biophys J 31:118–125
Schulze E, Ferrucci JT Jr, Poss K, Lapointe L, Bogdanova A, Weissleder R (1995) Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest Radiol 30:604–610
Koch AM, Reynolds F, Kircher MF, Merkle HP, Weissleder R, Josephson L (2003) Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjug Chem 14:1115–1121
Daldrup-Link HE, Rudelius M, Piontek G, Metz S, Brauer R, Debus G, Corot C, Schlegel J, Link TM, Peschel C, Rummeny EJ, Oostendorp RA (2005) Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 234:197–205
Smirnov P, Gazeau F, Lewin M, Bacri JC, Siauve N, Vayssettes C, Cuenod CA, Clement O (2004) In vivo cellular imaging of magnetically labeled hybridomas in the spleen with a 1.5-T clinical MRI system. Magn Reson Med 52:73–79
Zhang Z, van den Bos EJ, Wielopolski PA, de Jong-Popijus M, Duncker DJ, Krestin GP (2004) High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner. Magma 17:201–209
Cahill KS, Germain S, Byrne BJ, Walter GA (2004) Non-invasive analysis of myoblast transplants in rodent cardiac muscle. Int J Cardiovasc Imaging 20:593–598
Riviere C, Boudghene FP, Gazeau F, Roger J, Pons JN, Laissy JP, Allaire E, Michel JB, Letourneur D, Deux JF (2005) Iron oxide nanoparticle-labeled rat smooth muscle cells: cardiac MR imaging for cell graft monitoring and quantitation. Radiology 235:959–967
Yano S, Kuroda S, Shichinohe H, Hida K, Iwasaki Y (2005) Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct?-a double labeling study. Brain Res 1065:60–67
Daldrup-Link HE, Meier R, Rudelius M, Piontek G, Piert M, Metz S, Settles M, Uherek C, Wels W, Schlegel J, Rummeny EJ (2005) In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 15:4–13
Brillet PY, Gazeau F, Luciani A, Bessoud B, Cuenod CA, Siauve N, Pons JN, Poupon J, Clement O (2005) Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: comparative studies with ferumoxtran and anionic iron oxide nanoparticles. Eur Radiol 15:1369–1377
Daldrup-Link HE, Rudelius M, Oostendorp RA, Jacobs VR, Simon GH, Gooding C, Rummeny EJ (2005) Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Acad Radiol 12:502–510
Bos C, Delmas Y, Desmouliere A, Solanilla A, Hauger O, Grosset C, Dubus I, Ivanovic Z, Rosenbaum J, Charbord P, Combe C, Bulte JW, Moonen CT, Ripoche J, Grenier N (2004) In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 233:781–789
Shapiro EM, Sharer K, Skrtic S, Koretsky AP (2006) In vivo detection of single cells by MRI. Magn Reson Med 55:242–249
Schneider A, Attaran M, Gratz KF, Bleck JS, Winkler M, Manns MP, Ott M (2003) Intraportal infusion of 99mtechnetium-macro-aggregrated albumin particles and hepatocytes in rabbits: assessment of shunting and portal hemodynamic changes. Transplantation 75:296–302
Muraca M, Neri D, Parenti A, Feltracco P, Granato A, Vilei MT, Ferraresso C, Ballarin R, Zanusso GE, Giron G, Rozga J, Gerunda G (2002) Intraportal hepatocyte transplantation in the pig: hemodynamic and histopathological study. Transplantation 73:890–896
Acknowledgements
This work was supported in part by the following grants: Canceropole Ile de France—INCa—2004; ACI Neurosciences 03-5-295; GIS Maladies Rares A 03 087 DS.The authors wish to thank the MR team of the Imaging Department at CHU Henri Mondor, Faculte de Medecine Paris XII, Creteil, France, and especially Dr Pierre Brugières (MD) and Pierre Zerbib for their contribution in MR experiments. We also thank Dr Catherine Vayssettes for her help in animal experiments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luciani, A., Parouchev, A., Smirnov, P. et al. In vivo imaging of transplanted hepatocytes with a 1.5-T clinical MRI system—initial experience in mice. Eur Radiol 18, 59–69 (2008). https://doi.org/10.1007/s00330-007-0750-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-007-0750-7